Hepatitis B‐related serological events in hematopoietic stem cell transplant patients and efficacy of lamivudine prophylaxis against reactivation

Publisher： John Wiley & Sons Inc

E-ISSN： 1099-1069|34|3|140-146

ISSN： 0278-0232

Source： Hematological Oncology (Electronic), Vol.34, Iss.3, 2016-09, pp. : 140-146

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lamivudine: Hepatitis B reactivation: case report

By  

Reactions Weekly, Vol. 1, Iss. 1171, 2007-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

Infliximab: Lamivudine resistance and reactivation of hepatitis B infection: case report

By  

Reactions Weekly, Vol. 1, Iss. 1184, 2008-01 ,pp. : 23-23

Adis International

Access to resources Recommend Favorite

Lamivudine withdrawal: Fatal hepatitis B virus reactivation: 2 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1080, 2005-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Lamivudine for chronic hepatitis B - dosage in paediatric patients

By  

Inpharma, Vol. 1, Iss. 1231, 2000-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite

Busulfan in hematopoietic stem cell transplant setting

By McCune Jeannine S   Holmberg Leona A  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 5, Iss. 8, 2009-08 ,pp. : 957-969

Informa Healthcare

Access to resources Recommend Favorite